In the present study, we found that overexpression of EPIC1 enhanced the glioma progression, while downregulation of EPIC1 exhibited antitumor activity in glioma, indicating that EPIC1 plays an oncogenic role in glioma. This evidence concerns the gene EPIC1 and central nervous system cancer.